Page last updated: 2024-11-05

tinidazole and Leishmaniasis, Visceral

tinidazole has been researched along with Leishmaniasis, Visceral in 1 studies

Tinidazole: A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.
tinidazole : 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bano, P1
Shahab, SM1

Other Studies

1 other study available for tinidazole and Leishmaniasis, Visceral

ArticleYear
A combination of sulphadiazine, trimethoprim and metronidazole or tinidazole in kala-azar.
    The Journal of the Association of Physicians of India, 1994, Volume: 42, Issue:7

    Topics: Adult; Animals; Drug Therapy, Combination; Female; Humans; Leishmania donovani; Leishmaniasis, Visce

1994